Dupilumab as add-on biologic improved allergic asthma outcomes
www.pulmccm.org
by Salynn Boyles, Contributing Writer, MedPage Today SEATTLE -- Add-on treatment with the biologic therapy dupilumab (Dupixent) was associated with reduced severe exacerbations and improved lung function in patients with allergic asthma in a post-hoc analysis of phase III data from the
Dupilumab as add-on biologic improved allergic asthma outcomes
Dupilumab as add-on biologic improved…
Dupilumab as add-on biologic improved allergic asthma outcomes
by Salynn Boyles, Contributing Writer, MedPage Today SEATTLE -- Add-on treatment with the biologic therapy dupilumab (Dupixent) was associated with reduced severe exacerbations and improved lung function in patients with allergic asthma in a post-hoc analysis of phase III data from the